Regional Insights: China and India Leading the Asia Pacific Insomnia Market
The Asia Pacific Insomnia Market is dominated by China and India due to increasing urbanization, rising stress levels, and high smartphone usage among working populations. These countries have witnessed a surge in insomnia prevalence, driving the adoption of advanced therapies and sleep monitoring devices.
Government initiatives promoting sleep health awareness, coupled with expanding healthcare infrastructure, are accelerating market growth. Telemedicine and digital therapeutics are gaining traction in both urban and semi-urban areas.
Market Outlook: Valued at USD 2.1 billion in 2024, the market is projected to reach USD 4.2 billion by 2034, growing at a 7.0% CAGR.